Moody Lynn & Lieberson’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,280
Closed -$789K 219
2017
Q4
$789K Buy
+4,280
New +$768K 0.08% 118
2017
Q2
Sell
-51,487
Closed -$12.3M 228
2017
Q1
$12.3M Buy
51,487
+12,744
+33% +$2.97M 1.73% 16
2016
Q4
$8.14M Buy
+38,743
New +$8.03M 1.17% 36
2016
Q3
Sell
-1,178
Closed -$272K 185
2016
Q2
$272K Buy
+1,178
New +$272K 0.05% 141
2016
Q1
Sell
-713
Closed -$223K 198
2015
Q4
$223K Sell
713
-53,659
-99% -$16M 0.04% 164
2015
Q3
$14.8M Buy
54,372
+15,314
+39% +$4.7M 2.84% 5
2015
Q2
$11.9M Buy
39,058
+3,764
+11% +$1.12M 1.89% 12
2015
Q1
$10.5M Buy
35,294
+6,133
+21% +$1.75M 1.68% 16
2014
Q4
$7.51M Sell
29,161
-2,777
-9% -$694K 1.07% 33
2014
Q3
$7.71M Buy
31,938
+26,097
+447% +$5.84M 1.15% 29
2014
Q2
$1.3M Sell
5,841
-26,047
-82% -$5.39M 0.18% 97
2014
Q1
$6.56M Buy
31,888
+8,158
+34% +$1.62M 0.95% 43
2013
Q4
$3.99M Buy
+23,730
New +$3.71M 0.54% 72

Other funds holding AGN

Moody Lynn & Lieberson's AGN Position: Q1 2018 in Review

Moody Lynn & Lieberson sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 4,280 shares — an estimated $789K sold.

Moody Lynn & Lieberson first reported a position in AGN in Q4 2013 and held it in 13 quarters. The position peaked at $14.8M in Q3 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Moody Lynn & Lieberson reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 4,280 Allergan plc shares in Q1 2018, an estimated $789K.
  • Moody Lynn & Lieberson first reported a position in Allergan plc in Q4 2013 and held it in 13 quarters.
  • Moody Lynn & Lieberson's Allergan plc position peaked at $14.8M in Q3 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Moody Lynn & Lieberson's 13F filing for Q1 2018, filed 27 Apr 2018.